Dudediligence.

Scholar Rock Holding Corporation

SRRKNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$64.5MSep ’24−$66.5MDec ’24−$74.7MMar ’25−$110.0MJun ’25−$102.2MSep ’25−$91.0MDec ’25−$105.5MMar ’26−$109.9MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$18.8M$33.2Mnone on filenone on file$0.00
Operating income−$129.9M−$134.4M−$171.3M−$252.1M−$384.6M
Net income−$131.8M−$134.5M−$165.8M−$246.3M−$377.9M
Operating cash flow−$126.8M−$132.7M−$145.2M−$200.9M−$300.0M
Free cash flow−$132.0M−$133.8M−$145.3M−$201.0M−$300.6M
Cash$212.8M$103.3M$101.9M$177.9M$323.5M
Debt$50.0M$49.7M$50.0M$50.1M$99.7M
Shares outstanding35.2M51.7M76.0M93.8M108.5M